Preeclampsia Diagnostics Market Size, Share & Industry Analysis, By Test Type (Blood Tests and Urine Analysis), By Product (Instruments and Consumables) End-user (Hospitals, Specialty Clinics, Diagnostic Centers, and Others) and Regional Forecast, 2020-2029 (Includes COVID-19 Business Impact)

                                          
We have updated Preeclampsia Diagnostics Market with respect to COVID-19 Business Impact.
Inquire before buying


This report focuses on the Preeclampsia Diagnostics market and value at the global level, regional level, and company level. From a global perspective, this report represents the overall Preeclampsia Diagnostics market size by analyzing historical data and future prospects. Regionally, this report focuses on several key regions: North America, Europe, Japan, China, Southeast Asia, India, Latin America, and South America.


Global Preeclampsia Diagnostics Market: Segment Analysis


The research report includes specific segments by region (country), by Company, by Type, and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2019 to 2029. An in-depth analysis of the segments assists in identifying the different factors that will aid market growth.


Global Preeclampsia Diagnostics Market: Regional Analysis


The research report includes a detailed study of regions of North America, Europe, Japan, China, Southeast Asia, India, Latin America, and South America. The report has been curated after observing and studying various factors that determine regional growth such as the economic, environmental, social, technological, and political status of the particular region. Researchers have studied the data of revenue, sales, and manufacturers of each mentioned region. This section analyses region-wise revenue and volume for the forecast period of 2019 to 2029.


Global Preeclampsia Diagnostics Market: Competitive Landscape


This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and sales by manufacturers during the forecast period of 2019 to 2029.
List of Companies Profiled

Strong Product Offerings by Key Players Likely to Propel the Preeclampsia Diagnostics Industry Growth
F. Hoffmann-La Roche Ltd., PerkinElmer Inc., and DRG INSTRUMENTS GMBH are the leading players in the preeclampsia diagnosis market with a strong brand presence combined with a wide range of product offerings. These players are likely to continue their dominance in the preeclampsia diagnostics area and generate significant revenue in the forthcoming years. It is because of their persistent investments in the research and development activities for the launch of cost-effective and highly advanced diagnostic kits to rapidly detect preeclampsia. Moreover, a strong focus on the strategic collaborations with other players & various research organizations for the development of effective tests for preeclampsia is likely to support the expansion of their footprints in the preeclampsia diagnostics market.
Other players engaged in the manufacturing and distribution of preeclampsia diagnostics market include Thermo Fisher Scientific Inc., Diabetomics, Inc., Metabolomic Diagnostics Ltd., Sera Prognostics, Siemens Healthineers AG, and Bayer AG among others.

LIST OF KEY COMPANIES PROFILED:

  
F. Hoffmann-La Roche Ltd
  
PerkinElmer Inc.
  
DRG INSTRUMENTS GMBH
  
Thermo Fisher Scientific Inc.
  
Diabetomics, Inc.
  
Metabolomic Diagnostics Ltd.
  
Sera Prognostics
  
Siemens Healthineers AG
  
Bayer AG
  
Others

REPORT COVERAGE
The preeclampsia diagnosis market report provides detailed information regarding various insights of the market. Some of them are growth drivers, restraints, competitive landscape, regional analysis, and challenges. It further offers an analytical depiction of the preeclampsia diagnostics market trends and estimations to illustrate the forthcoming investment pockets. The market is quantitatively analyzed from 2015 to 2026 to provide the financial competency of the market. The information gathered in the report has been taken from several primary and secondary sources.

Report Scope & Segmentation

Segmentation

By Test Type

  
Blood Tests
  
Urine Analysis

By Product Type

  
Instruments
  
Consumables

By End-user

  
Hospitals
  
Specialty Clinics
  
Diagnostic Centers
  
Others

By Region

  
North America
  
Europe
  
Asia Pacific
  
Latin America
  
The Middle East & Africa

INDUSTRY DEVELOPMENT:

February 2016: Diabetomics, Inc. announced its strategic partnership with BD to conduct a newly developed pregnancy-specific metabolic assay for the early detection of preeclampsia and gestational diabetes.

March 2015: Siemens Healthineers AG launched two new advanced urine testing solutions for the U.S. central laboratories, namely, the CLINITEK Novus Automated Urine Chemistry Analyzer and the CLINITEK AUWi PRO Automated Urine Workstation

February 2015: Metabolomic Diagnostics Ltd. received an overall funding of ‚¬1.5 million from SOSventures, Enterprise Ireland and the AIB Seed Capital Fund. Through this funding, the company aims to expand its research study in metabolic biomarkers for the preeclampsia diagnosis.